4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001650664-26-000105
CEO sold 21,164 shares at $2.42 ($51,122)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
O'Neill Gilmore Neil · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-11 | Sale : show line 1 in the form 10b5-1 | −21,164 | $2.42 | $51,122 | 265,592 | D |
| Open-market sales · 21,164 sh · avg $2.42 · $51,122 | ||||||
Loading xslF345X06/wk-form4_1794605645.xml…